Cargando…

DNA methylation biomarkers in peripheral blood of patients with head and neck squamous cell carcinomas. A systematic review

BACKGROUND: Head and neck squamous cell carcinomas (HNSCC) are often diagnosed in advanced stages. In search of new diagnostic tools, focus has shifted towards the biological properties of the HNSCC, and the number of different biomarkers under investigation is rapidly growing. OBJECTIVES: The objec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danstrup, Christian Sander, Marcussen, Mette, Pedersen, Inge Søkilde, Jacobsen, Henrik, Dybkær, Karen, Gaihede, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746174/ https://www.ncbi.nlm.nih.gov/pubmed/33332423 http://dx.doi.org/10.1371/journal.pone.0244101

Ejemplares similares

Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review
por: Terp, Simone Karlsson, et al.
Publicado: (2023)

The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
por: Nesic, Marijana, et al.
Publicado: (2021)

High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol
por: Pedersen, Inge Søkilde, et al.
Publicado: (2012)

DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma
por: Zhu, Yun, et al.
Publicado: (2019)

Biomarker driven treatment of head and neck squamous cell cancer
por: Eze, Nnamdi, et al.
Publicado: (2017)

CCTs as new biomarkers for the prognosis of head and neck squamous cancer
por: Dong, Yanbo, et al.
Publicado: (2020)

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review
por: Swartz, Justin E, et al.
Publicado: (2015)

T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
por: Wang, Xuefeng, et al.
Publicado: (2022)

Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma
por: Marcussen, Mette, et al.
Publicado: (2018)

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
por: Leblanc, Olivia, et al.
Publicado: (2020)

Exosomes: Potential Biomarkers and Functions in Head and Neck Squamous Cell Carcinoma
por: Li, Ting, et al.
Publicado: (2022)

DNA Methylation Induced Epigenetic Silencing: A Potential Biomarker and Therapeutic Target for Head and Neck Squamous Cell Carcinoma
por: Patil, Shankargouda, et al.
Publicado: (2015)

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation
por: Feng, Yao, et al.
Publicado: (2023)

Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma
por: Cao, Yu, et al.
Publicado: (2018)

Microbial and inflammatory‐based salivary biomarkers of head and neck squamous cell carcinoma
por: Vesty, Anna, et al.
Publicado: (2018)

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
por: Alfieri, Salvatore, et al.
Publicado: (2020)

HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma
por: Wu, Xiang, et al.
Publicado: (2021)

Corrigendum: Exosomes: Potential biomarkers and functions in head and neck squamous cell carcinoma
por: Li, Ting, et al.
Publicado: (2022)

Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma
por: Ju, Guoyuan, et al.
Publicado: (2023)

Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma
por: Bebek, Gurkan, et al.
Publicado: (2012)

Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
por: Degli Esposti, Davide, et al.
Publicado: (2017)

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021)

The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma
por: Zhao, Yaqiong, et al.
Publicado: (2022)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer
por: Theodoraki, Marie-Nicole, et al.
Publicado: (2023)

Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas
por: Colacino, Justin A., et al.
Publicado: (2012)

Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma
por: Boscolo-Rizzo, Paolo, et al.
Publicado: (2019)

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
por: Liouta, Galateia, et al.
Publicado: (2023)

Recent Advances in Biomarkers and Potential Targeted Therapies in Head and Neck Squamous Cell Carcinoma
por: Yavrouian, Eric J., et al.
Publicado: (2012)

The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas
por: Tang, Kai Dun, et al.
Publicado: (2017)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
por: Oliva, M, et al.
Publicado: (2019)

Integrin α-5 as a potential biomarker of head and neck squamous cell carcinoma
por: Zou, Bo, et al.
Publicado: (2019)

Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck
por: Kunder, Shreya, et al.
Publicado: (2021)

Bioinformatics analysis for the biomarkers of the tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma
por: You, Yuanhe, et al.
Publicado: (2021)

Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
por: Park, Jong Chul, et al.
Publicado: (2022)

FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
por: Wu, Qingqing, et al.
Publicado: (2022)

Utility of miRNA biomarkers for detection of early head and neck squamous cell carcinoma
por: Ershadifar, Soroush, et al.
Publicado: (2023)

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
por: Huang, Xiaomin, et al.
Publicado: (2023)

Cuproptosis combines immune landscape providing prognostic biomarker in head and neck squamous carcinoma
por: Shu, Tingting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_686ub1aes44e83ddrsk00iagn2